BioStar gains distribution of chlamydia test:
This article was originally published in Clinica
General Injectables and Vaccines has added BioStar's Chlamydia Optical ImmunoAssay point-of-care test to the antibiotic Zithromax which it is already distributing for Pfizer. General Injectables agreed a joint marketing deal with BioStar, a privately-held company in Boulder, Colorado, which specialises in developing point-of-care tests for infectious diseases.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.